Volume 270,
Number 9,
Issue of March 3, 1995 pp. 4721-4728
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Transport of
Metal-binding Peptides by HMT1, A Fission Yeast ABC-type Vacuolar
Membrane Protein (*)
(Received for publication, July 29, 1994; and in revised form, November
28, 1994)
Daniel F.
Ortiz (§), ,
Theresa
Ruscitti,
Kent F.
McCue ,
David W.
Ow (¶)
From the Plant Gene Expression Center, USDA/ARS, Albany,
California 94710 and the Department of Plant Biology, University of
California, Berkeley, California 94720
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES
ABSTRACT
The Schizosaccharomyces pombe hmt1 gene encodes an ABC
(ATP-binding cassette)-type protein essential for Cd
tolerance. Immunoblot analysis of subcellular fractions indicates
that the native HMT1 polypeptide is associated with the vacuolar
membrane. Vacuolar membrane vesicles were purified from strains that
hyperproduce, or are deficient in, the HMT1 protein. In vitro transport of radiolabeled substrates by these vesicles indicates
that HMT1 is an ATP-dependent transporter of phytochelatins, the
metal-chelating peptides involved in heavy metal tolerance of plants
and certain fungi. Vacuolar vesicles containing HMT1 are capable of
taking up both apo-phytochelatins and phytochelatin-Cd
complexes. HMT1 activity is sensitive to antibodies directed
against this protein and to vanadate, but not to inhibitors affecting
the vacuolar proton ATPase or ionophores that abolish the pH gradient
across the vacuolar membrane. Vacuolar uptake of Cd
and of a glutathione conjugate were also observed, but are not
attributable to HMT1. These studies highlight the importance of the
yeast vacuole in detoxification of xenobiotics.
INTRODUCTION
ABC (
)(ATP-binding cassette)-type proteins represent
one of the largest known families of membrane transporters(1) .
Members of this superfamily are characterized by the presence of a
highly conserved nucleotide-binding domain that is associated with a
more variable region capable of spanning the membrane multiple times.
DNA sequence analysis indicated that the Schizosaccharomyces pombe
hmt1 (heavy metal tolerance 1)
gene, essential for Cd
tolerance, encodes an ABC-type
protein(2) . Most eukaryotic ABC-type polypeptides exhibit a
duplicated structure, containing two transmembrane and two
nucleotide-binding domains. HMT1, on the other hand, has only one of
each. The few known eukaryotic ABC-type proteins that exhibit this
nonduplicated arrangement reside in internal membranes: rat PMP70 (3) and its human homologue (4) in the peroxisome and
TAP1 and TAP2 in endoplasmic reticulum and cis-Golgi(5) .
Previously we reported that an HMT1-
-galactosidase fusion protein
was localized to the fission yeast vacuole(2) .
ABC-type
proteins can mediate tolerance to a wide diversity of cytotoxic agents.
Multiple drug resistance proteins from mammals (reviewed in (6) ) and yeast (7, 8) decrease the toxicity
of a variety of anti-tumorigenic drugs. Leishmania IgptA
confers tolerance to methotrexate and arsenite(9) , and a
number of bacterial transporters are involved in resistance to
antibiotics and environmental toxins (reviewed in (10) ).
Resistance is achieved by export of the toxic substances from the cell.
The intracellular location of the HMT1-
-galactosidase chimera, on
the other hand, suggested that this protein might represent the first
example of an ABC-type transporter mediating resistance to a toxin by
sequestration in an intracellular membrane-bound compartment. The
nature of the substrate transported by HMT1, and its role in heavy
metal tolerance of fission yeast were not clear.
Plants and certain
fungi, including S. pombe, respond to heavy metals by inducing
synthesis of small peptides known as phytochelatins
(PCs)(11, 12, 13) . Unlike metallothioneins,
PCs are not produced by mRNA translation but are enzymatically
synthesized from glutathione (GSH,
-Glu-Cys-Gly). PCs have the
general structure (
-Glu-Cys)
Gly, where n = 2-11, and like metallothioneins, chelate heavy
metals by formation of thiolate bonds. Yeast and plant cells exposed to
Cd
accumulate a low molecular weight (LMW) PC
Cd
complex, consisting mostly of PCs and Cd
, and a high
molecular weight (HMW) PC
Cd
S
complex,
containing acid labile sulfide (14, 15, 16) .
Genetic and biochemical analyses suggest that production of the sulfide
moiety in the HMW PC
Cd
S
complex involves
the purine biosynthetic pathway(17, 18) . The HMW
complex, a CdS crystallite coated by PC peptides(19) , has a
higher Cd
-binding capacity than LMW PC
Cd, and
the Cd
ions are less susceptible to acid
displacement(20) . Although detailed structures for HMW and LMW
PC
Cd complexes are not available, it is clear that both are
heterogeneous oligomeric aggregates containing multiple PC peptides of
variable length.
Since overexpression of hmt1 in yeast
cells confers enhanced Cd
tolerance, as well as
accumulation of the metal(2) , it was postulated that HMT1 was
involved in vacuolar sequestration of heavy metals or metal-peptide
complexes. In this report we describe the localization of native HMT1
protein to vacuolar membranes and the discovery of an ATP-dependent PC
transport activity in vacuolar membrane vesicles. We present evidence
showing that HMT1 is responsible for this activity and describe the
substrate specificity and energy requirements of this transporter. In
addition, we observed Cd
and glutathione conjugate
transport activities in fission yeast vacuolar vesicles lacking
detectable amounts of HMT1 protein.
MATERIALS AND METHODS
Yeast Strains
The S. pombe strain Sp223
(h
, ade6-216, leu1-32,
ura4-294) is used as a wild type control in these
experiments. The hmt1
mutant, LK100, was
derived from Sp223 by ethyl methanesulfonate-induced
mutagenesis(2) . In most analyses LK100 contains either the
yeast expression vector pART1 or pDH35 (pART1 containing an hmt1 cDNA)(2) . Cultures were grown at 30 °C in S.D. (6.7 g
of Difco yeast nitrogen base, 20 g of glucose/liter, adenine and uracil
at 20 µg/ml).
Antibodies Directed against HMT1
A 760-base pair ClaI-MaeIII cDNA fragment encoding amino acids
553-806 of HMT1 was subcloned into the Qiagen pQIA16/17 vector
system (pDH60). A 29-kDa His-tagged product, purified by Ni-agarose
affinity chromatography from Escherichia coli, was used to
immunize rabbits 622 and 623. Antisera 622 and 623 recognized a 29-kDa
peptide in E. coli/pDH60 that was isopropyl
-thiogalactopyranoside inducible, but was not detected in E.
coli/pQIA16. Preimmune sera failed to recognize this protein. IgG
was purified from 622 and 623 antisera using Protein A-agarose
(Bio-Rad).Plasmid pDH30(2) , containing an hmt1 cDNA in the pBluescript SK vector (Stratagene), was used for in vitro transcription/translation by the TnT T7 system
(Promega) in the presence of [
S]Met (1141
Ci/mmol, DuPont). Canine pancreatic microsomal membranes (Promega) were
added according to the manufacturer's instructions. Translation
products were immunoprecipitated using Protein A-agarose or directly
separated by 10% SDS-polyacrylamide gel electrophoresis for
fluorography.
Isolation of Vacuole Membrane Vesicles
S.
pombe vacuolar vesicles were isolated as described previously (2) with the following modifications. All buffers contain 2
mM benzamidine, 4 µg/ml leupeptin, 4 µg/ml pepstatin
A, and 1 mM phenylmethylsulfonyl fluoride. Spheroplasts were
lysed in Buffer A (1.6 M sorbitol, 10 mM MES-Tris, pH
6.9, 0.5 mM MgCl
) with a glass homogenizer.
Unlysed cells were pelleted by centrifugation at 2,500
g for 10 min. A half-volume of Buffer B (Percoll containing 1.6 M sorbitol, 10 mM MES-Tris, pH 6.9, 1 mM MgCl
) was added to the supernatant (final Percoll
concentration of 30%) and the vacuoles pelleted at 15,000
g for 30 min. The vacuole pellet was resuspended in Buffer A with a
homogenizer, mixed with a half-volume of Buffer B, layered on a cushion
of equal volumes of Buffers A and B (50% Percoll), and pelleted as
before. The vacuolar pellet was resuspended in Buffer C (100 mM KCl, 10 mM MES-Tris, pH 6.9, 5 mM MgCl
) and vacuolar membrane vesicles pelleted at 7,000
g for 10 min. Vacuolar vesicles were resuspended in
0.5-1.5 ml of Buffer C containing 0.25 M sucrose and
frozen in liquid nitrogen as 50-µl aliquots.
Enzyme Assays
Specific activities of marker
enzymes were compared in total membranes and vacuolar membrane
vesicles. To prepare total membranes for marker enzyme analysis, an
aliquot of the 2,500
g cell-free supernatant from the
vacuolar preparation was diluted 10-fold with Buffer C and membranes
pelleted by centrifugation at 100,000
g. The
particulate fraction was resuspended in Buffer C with 0.25 M sucrose and frozen in liquid nitrogen.
-Mannosidase,
cytochrome c-reductase, dipeptidyl aminopeptidase B,
glucose-6-phosphate dehydrogenase, and ATPase activities were measured
as described(21) . Succinate dehydrogenase (22) and
Golgi GDPase (23) were determined as reported. Quenching of
acridine orange fluorescence was measured with a Perkin Elmer LS5
Fluorescence spectrometer(24) , except that EDTA was omitted
from the reaction buffer. Protein concentration was determined using
the Bradford assay (Bio-Rad) containing 0.05% CHAPS. The values
obtained by modified Lowry assay on trichloroacetic acid-precipitated
material were not significantly different from those generated with the
Bradford assay.
Synthesis and Purification of Substrates
Sp223
cells grown in 800 ml of S.D. to an A
of
0.6-0.8 were incubated with 0.25 mCi/liter of
[
S]Cys (Amersham, 1300 Ci/mmol) and 0.4 mM CdSO
for 8 h. Cells were lysed with glass beads in 1.5
volumes of 50 mM Tris, pH 7.6, 100 mM KCl, 0.1 mM CdCl
, 0.5% isoamyl alcohol and centrifuged at 10,000
g for 10 min. Elution of PC
Cd complexes from
DEAE-Sephacel (Pharmacia Biotech Inc.) with a linear KCl gradient
(0.2-0.5 M, 10 mM Tris, pH 7.6) generated two
well resolved peaks of
S-labeled material. Extracts
labeled with
CdCl
instead of
[
S]Cys produced an identical column profile.
S-Labeled fractions were reduced in volume to 4 ml in
vacuo and applied to a Sephadex G-50 column as
described(2) . The positions of
S peaks in the
G-50 elution profile were consistent with purification of HMW and LMW
PC
Cd complexes. These peaks could also be labeled by addition of
a
CdCl
tracer to the sample before loading.
Concentrated G-50 column fractions, desalted by Sephadex G-10
chromatography, were used in transport studies. HPLC analysis of the
PC
Cd complexes (essentially as described in (25) , except
that trifluoroacetic acid was substituted with 0.1%
H
PO
) indicated that the PCs were mostly of n = 2-3, in agreement with Grill et
al.(26) , and did not contain GSH. Apo-PCs were prepared
from the LMW [
S]PC
Cd complex by
acidification to pH 2.0 with 1 N HCl followed by HPLC
separation(20) .
S-Labeled HPLC fractions were
neutralized and desalted by Sephadex G-10 chromatography. The LMW
[
S]PC
Cd complex reconstituted from apo-PCs
and Cd
was indistinguishable from the native complex
by Sephadex G-50 gel filtration or as a substrate in transport assays.
A LMW [
S]PC
Cd complex could also be
derived from purified HMW
[
S]PC
Cd
S
complex
by acidification with 1 N HCl to pH 2.0 in the presence of 10
mM
-mercaptoethanol(20) . After out-gassing the
evolved H
S, the reaction was neutralized using NaOH, and
subjected to Sephadex G-50 gel chromatography. Greater than 90% of the
counts present in the HMW
[
S]PC
Cd
S
complex
were recovered from G-50 as a peak indistinguishable from the native
LMW [
S]PC
Cd complex. This same peak could
also be labeled by addition of a
Cd tracer. PC
concentration was measured with Ellman's reagent (27) and
interpolated on a GSH standard curve. Because native PC
Cd
complexes are heterogeneous regarding number of peptides per complex
and length of peptides, PC concentrations are reported as GSH
equivalents. Unlabeled PC
Cd complexes were prepared in
essentially the same manner. Cd
content of column
fractions was quantified by atomic absorption spectroscopy as described
previously (2) .
Cd was incorporated into LMW
PC
Cd complexes of known Cd
and thiol
concentration by incubation with
CdCl
for 30
min on ice. Free Cd
ions were separated from the LMW
[
Cd]PC
Cd complex by G-10 chromatography. [
H]GSSG was prepared from
[
H]GSH (300 mCi/mmol, DuPont)(28) . The
2,4-dinitrophenyl-S-glutathione conjugate (GSDNP) was
enzymatically synthesized from 1-chloro-2,4-dinitrobenzene (Sigma) and
[
H]GSH by glutathione S-transferase
(Sigma)(29) . [
H]GSDNP was separated from
its precursors by thin layer chromatography and quantified by
absorbance at 340 nm.
Vesicle Filtration Assay
Vesicle filtration assays
were performed at 30 °C in 10 mM MES-Tris, pH 7.8, 20
mM KCl, 5 mM MgCl
, 10 mM creatine phosphate, and 100 µg/ml creatine kinase (Buffer D).
50 µl of thawed vacuolar vesicles (20-50 µg of protein)
were resuspended in 200 µl of Buffer D, ATP added to a final
concentration of 3 mM, and 50 µl of radiolabeled substrate
added 30 s later. At the times indicated in the figures, 50-µl
aliquots from the reaction were diluted to 1 ml with ice-cold Buffer D,
filtered immediately under light vacuum through a 25-mm GF-C filter
(Whatman), and washed with 5 ml of Buffer D. For Cd
transport, 50 µl of 48 µM
CdCl
, 100 mCi/mmol (DuPont) was used (8
µM final concentration), and the wash contained 2 mM CdCl
to reduce nonspecific binding of Cd
to membranes. For [
H]GSDNP uptake studies,
a final concentration of 50 µM GSDNP was used. For PC
uptake studies, a solution containing 50,000 cpm of
S-labeled PCs (4-8 µM GSH equivalents)
was used. For measurement of [
Cd]PC
Cd
uptake, the LMW [
Cd]PC
Cd substrate was
present at a final concentration of 8 µM Cd
and 16.4 µM GSH equivalents. For antibody inhibition
of PC uptake, an aliquot of vacuolar vesicles was mixed with Buffer D
and incubated on ice for 1 h with preimmune serum, no antibody, or 300
µg of IgG derived from either antiserum 622 or 623. ATP and PC
substrates were added and the vesicle filtration assay conducted as
above.
RESULTS
hmt1 Encodes a 90-kDa Vacuolar Membrane
Protein
An HMT1-
-galactosidase fusion protein had
previously been localized to the vacuolar membrane of S.
pombe(2) . However, reports indicating that
hyperproduction of a membrane protein may result in mislocalization to
the vacuole (30) and that the vacuolar membrane may represent
the default sorting pathway for yeast membrane proteins (31) suggested that addition of the 105-kDa
-galactosidase
peptide to the carboxyl terminus of HMT1 may have altered its
subcellular sorting. Therefore, the intracellular location of native
HMT1 remained uncertain.A 29-kDa peptide, encompassing most of the
HMT1 ATP-binding cassette domain, was synthesized in E. coli,
purified, and used to raise antibodies (antisera 622 and 623). Both
antisera recognized a 90-kDa protein in S. pombe (Fig. 1A) that was not detected by preimmune sera
and is consistent with the 90.5-kDa molecular mass predicted for HMT1.
The 90-kDa protein was associated with the P100 (100,000
g precipitable) particulate fraction of S. pombe extracts (lane g), but is not detected in the S100 supernatant (lane e), as expected of an integral membrane protein.
Figure 1:
A, immunoblot of S. pombe proteins using antiserum 622. Lanes contain 2 µg of protein
from vacuolar membrane vesicles prepared from: (a) LK100/pDH35 (hmt1
mutant complemented by an hmt1 cDNA in pART1); (b) Sp223/pART1 (hmt1
strain with empty vector); and (c) LK100/pART1. 40
µg of protein from: (d) a P100 (100,000
g precipitable) pellet derived from the supernatant overlying the
purified vacuole pellet and (e) the S100 (supernatant)
fraction of Sp223/pART1. 50 µg of protein from the P100 fractions
of extracts made from: (f) LK100/pDH35; (g)
Sp223/pART1; and (h) LK100/pART1. The blot was overdeveloped
to show the lack of HMT1 in LK100/pART1 lanes. The smaller bands (62
and 39 kDa) recognized by the antibody varied in intensity in different
experiments and are probably produced by proteolytic degradation of
HMT1. Similar effects have been reported with preparations of mammalian
P-glycoprotein(32) . B, Coomassie stained replica of
the portion of the gel (lanes a-c) shown in A that
contains vacuolar membranes.
Vacuoles were prepared from S. pombe spheroplasts as
described under ``Materials and Methods.'' Compared to the
particulate fraction of a total cellular extract, purified vacuolar
vesicles are highly enriched in vacuolar marker enzymes and
impoverished in markers for mitochondrial, Golgi, endoplasmic
reticulum, and plasma membranes (Table 1). In the immunoblot in Fig. 1A, lanes loaded with vacuolar membranes (Fig. 1A, lanes a and b) exhibited enrichment
of the hmt1 product when compared with total cellular
membranes (lanes f and g) despite containing 25-fold
less protein. The supernatant overlying the vacuolar pellet was
impoverished in HMT1 (lane d), suggesting that this protein is
sorted primarily to the vacuolar membrane. Cd
treatment of wild type cultures did not alter levels of the
90-kDa protein (not shown).
The 90-kDa polypeptide was not detected
in total (lane h), or vacuolar (lane c), membranes
derived from the Cd
-sensitive LK100 strain, which
bears an hmt1
allele with a nonsense
mutation in the 5` region of the gene(2) . Strains transformed
with the pDH35 plasmid accumulate high levels of the hmt1 mRNA (2) and 90-kDa peptide (Fig. 1A, lanes a and f and B, lane a).
In Vitro Transcription/Translation of hmt1
cDNA
In vitro transcription/translation of the hmt1 cDNA generated a 90-kDa product, but only if canine pancreatic
microsomes or Triton X-100 detergent were present in the reaction (Fig. 2A). In vitro translation of other
integral membrane proteins (33, 34) also depend on
these additives. The apparent M
of hmt1 translation products obtained with Triton X-100 and canine
microsomes was the same, suggesting that the hmt1 gene product
was not glycosylated in vitro upon insertion into microsomes.
The in vitro translation product also co-migrated with the
90-kDa band present in vacuolar membrane extracts (see Fig. 1B), suggesting that HMT1 may not be glycosylated in vivo either. Translation products were immunoprecipitated
with antisera 622 and 623 but not preimmune sera (Fig. 2B). In addition to the 90-kDa product, several
smaller peptides generated in the transcription/translation reaction
were also recognized by the antisera. Since the antibodies are directed
to the carboxyl-terminal ABC domain of HMT1, the smaller products could
derive from use of cryptic transcription and/or translation start
signals present in the hmt1 cDNA. Highly hydrophobic proteins
are translated far less efficiently than soluble polypeptides (up to
40-fold lower than the luciferase and S. pombe ade2 gene
products). Use of the next downstream ATG codon, encoding Met-318, as a
translational start site would generate a truncated peptide lacking the
most hydrophobic region of HMT1. The M
of seven of
the eight smaller peptides present in the translation reaction mixture
match the sizes predicted if downstream Met codons were used as
intragenic translational start sites. Production of these smaller
peptides is not dependent on microsomes or detergent; therefore, their
translation might be more efficient than that of the full-length HMT1.
Figure 2:
In vitro transcription/translation of hmt1 cDNA. A,
fluorograph of an SDS-polyacrylamide gel electrophoresis gel containing
[
S]Met labeled in vitro translation
products derived from: (a) pBluescript SK+ canine
pancreatic microsomes; (b) pDH30 (pBluescript SK containing an hmt1 cDNA) without additives; (c) pDH30 + 1%
Triton X-100; (d) pDH30 + canine pancreatic microsomes. B, fluorograph of immunoprecipitated products from in
vitro transcription/translation of pDH30 in the presence of 1%
Triton X-100: (a) preimmune serum of rabbit 622; (b)
anti-HMT1 antiserum 622; (c) anti-HMT1 antiserum
623.
[
S]PC Uptake Is
HMT1-dependent
Possible functions of HMT1 include transport of
heavy metals and/or PC-metal complexes. Vacuolar membrane vesicles
isolated from mutant (LK100/pART) and HMT1 hyperproducing (LK100/pDH35)
strains were tested for uptake of radioactively labeled substrates by
the standard vesicle filtration assay. Vesicles derived from the HMT1
hyperproducer exhibited ATP-dependent uptake of in vivo labeled LMW [
S]PC
Cd complex (Fig. 3A). No activity was observed at 0 °C, in the
absence of ribonucleotides, or with AMP, ADP, or the non-hydrolyzable
ATP analog AMP-PNP. Inclusion of a creatine kinase/creatine phosphate
ATP-regeneration system resulted in a 1.6-fold increase in initial
uptake velocity and maintained linearity of uptake for a longer period
of time. LMW PC
Cd uptake has a K
for ATP of
0.38 ± 0.01 mM (Fig. 4). 3 mM UTP, CTP,
or GTP sustained 97 ± 3, 62 ± 1, or 54 ± 1%,
respectively, of the initial velocity measured with 3 mM ATP
in the absence of a regeneration system. Addition of Triton X-100 to
vesicles loaded with radiolabeled PCs resulted in a decrease of
S counts retained on the filter. Furthermore, a decrease
in the initial velocity of [
S]PC uptake was
observed upon reduction of the internal vesicle space (Fig. 5),
suggesting that PCs were transported into the vacuolar vesicles rather
than binding to the outside of the membrane.
Figure 3:
Uptake
of
S-labeled PC
Cd complexes by purified vacuolar
membrane vesicles. A, ATP-dependent uptake of LMW PC
Cd.
Vacuolar vesicles (20-40 µg of protein) prepared from the hmt1
mutant LK100 bearing the pART1 vector
containing an hmt1 cDNA (pDH35) (
,
) or no insert
(
,
) were incubated with 8 µM GSH
equivalents of LMW [
S]PC
Cd complex (50,000
cpm) in the presence (
,
) or absence (
,
) of 3
mM ATP and an ATP regeneration system. Aliquots were taken at
the times indicated and substrate uptake determined by the vesicle
filtration assay. Arrow indicates addition of Triton X-100 to
0.02%. B, comparison of uptake of LMW PC
Cd and HMW
PC
Cd
S
complex by vacuolar vesicles.
Vesicles from LK100/pDH35 were incubated with an equal number of counts
(50,000 cpm representing 6 µM GSH equivalents) of LMW
[
S]PC
Cd (
) or HMW
[
S] PC
Cd
S
(
) in the presence of ATP. Bars represent
S.E.
Figure 4:
Dependence of PC
Cd uptake on ATP
concentration. Double reciprocal plot of data used to calculate the K
of HMT1 for ATP. Linear regression
curve was calculated as described(35) . Inset: initial
velocity of LMW [
S]PC
Cd complex uptake
(calculated as in Table 2) by LK100/pDH35 vacuolar membrane
vesicles measured in the presence of an ATP regeneration system and
varying concentrations of ATP. Bars represent
S.E.
Figure 5:
Inhibition of PC
Cd uptake by
reduction of internal vesicle space. Uptake of LMW
[
S]PC
Cd complex was measured as described
in the legend to Fig. 3in the presence of 0.5, 0.75, 1.0, 1.25,
and 1.5 M sucrose. The initial uptake velocity (determined as
in Table 2) is plotted against the reciprocal of the sucrose
concentration. Bars represent S.E.
Unlike vesicles derived
from the HMT1 hyperproducing strain, LK100/pART1 vacuolar membrane
vesicles exhibited no ATP-dependent transport of the LMW
[
S]PC
Cd complex (Fig. 3A).
Very little activity was observed with membrane vesicles derived from
Sp223/pART1 (not shown), probably because of the relatively low level
of HMT1 protein present in wild type vacuoles (compare lanes a and b in Fig. 1B) and low specific
activity of the in vivo labeled PC substrate. The differences
in PC uptake activity among the various strains was not due to
differential labilities of vacuolar vesicles. Transport competency of
the isolated vacuolar vesicles were similar with regards to
Cd
and GSDNP (see below). Additionally, vacuolar
vesicles from all three strains exhibited comparable levels of
ATP-dependent [
C]arginine uptake (not shown), an
activity that is also present in vacuoles of Saccharomyces
cerevisiae(36) and Neurospora
crassa(37) .
One of the polyclonal antibodies directed
against HMT1 inhibited the PC transport activity in vitro.
Incubation of vacuolar vesicles with 1 mg/ml IgG purified from
antiserum 622 resulted in a 63% reduction in the initial velocity of PC
uptake (determined as in Table 2) from 2.8 ± 0.6 to 1.3
± 0.1 nmol/min/mg. Increasing antibody concentration did not
further inhibit PC uptake. IgG purified from antiserum 623 had no
effect on PC transport even at concentrations above 2 mg/ml IgG. The
lack of PC uptake by vacuoles derived from the HMT1-deficient mutant,
the high level of ATP-dependent PC transport observed in vacuolar
vesicles prepared from the HMT1 hyperproducing strain, and the
inhibition of PC uptake by antibodies directed against HMT1, all
indicate that the hmt1 gene encodes the PC transporter.
Vacuolar vesicle uptake of labeled PCs was challenged with a series
of inhibitors (Table 2). Vanadate, which inhibits the activity of
a number of ABC-type proteins, significantly inhibited PC uptake with
an IC
of 0.082 ± 0.004 mM. Bafilomycin A,
an inhibitor of vacuolar ATPase, nigericin, a proton-K
ionophore, and valinomycin, a K
ionophore, had
no significant effect, indicating that PC transport is not dependent on
the
pH across the vacuolar membrane.
The HMW PC
Cd
S
Complex Is
Not an Efficient Substrate
Cd-peptide complexes containing PCs
of the same length and of the same specific activity were prepared by
converting the
S-labeled HMW
PC
Cd
S
complex to the LMW form through
acid depletion of sulfide(20) . Conversion was confirmed by a
shift in the apparent M
of the
S-labeled PC
Cd complex and a reduction in absorbance
at 280 nm. Greater than 90% of the counts present in the HMW
[
S] PC
Cd
S
starting material were recovered from a Sephadex G-50 column as
LMW [
S]PC
Cd complex.Initial velocity
for ATP-dependent uptake of the LMW PC
Cd complex was 2.4
nmol/min/mg versus 0.7 nmol/min/mg for the HMW
PC
Cd
S
complex (Fig. 3B).
Estimating the precise difference in the rate with which these two
complexes were taken up is confounded by the variable number of PC
molecules per complex, over 25 in the HMW
PC
Cd
S
complex (19) compared with
3-8 in the LMW PC
Cd complex(38) . An additional
consideration is that the HMW PC
Cd
S
complex can spontaneously break down to form the LMW PC
Cd
form, thus it is unclear what proportion of counts taken up by the
vacuolar vesicles represents bona fide transport of the HMW complex.
Both of these factors lead to an overestimation of the rate of HMW
PC
Cd
S
transport, and an underestimation
of the difference in the relative affinity of HMT1 for these two
substrates.
Apo-PCs as a Transport Substrate
To test if PCs
need to be complexed with Cd
in order to be taken up
by HMT1, Cd
was stripped from LMW
[
S]PC
Cd by acidification, and HPLC
purified apo-[
S]PCs were tested for uptake by
vacuolar membrane vesicles. No significant difference was detected
between uptake of apo-PCs and LMW PC
Cd and no enhancement of
transport activity was observed upon supplementation of apo-PCs with
CdCl
(not shown). This suggests that the apo-PC peptides
can be transported by HMT1. However, Mg
has been
provided at a relatively high concentration (5 mM) as
transport of LMW PC
Cd is severely reduced in its absence.
Although PCs have a much lower affinity for Mg
than
metals ions such as Cd
or
Cu
(39) , it is possible that in the absence
of Cd
the thousand-fold excess of Mg
drives the formation of a PC
Mg complex, which is taken up
by vacuolar vesicles. Alternatively, trace amounts of other metals in
the vacuolar vesicle preparation may be forming a complex with the
apo-PCs.
Vacuoles Contain a Cd
Transporter That
Is Not HMT1
Cells overexpressing hmt1 hyperaccumulate
Cd
(2) . While this could be due to enhanced
vacuolar sequestration of PC
Cd complexes it was also possible
that HMT1 is directly involved in Cd
transport. Fig. 6A shows that
Cd was taken up by
vacuolar membrane vesicles in an ATP-dependent manner. AMP, ADP, and
non-hydrolyzable ATP analogs such as AMP-PNP did not support transport,
and uptake was abolished at 0 °C. However, vesicles derived from
LK100/pART1, LK100/pDH35 (Fig. 6A), or Sp223/pART (not
shown) displayed very little difference in Cd
uptake,
suggesting that HMT1 is not responsible for this activity.
Cd
uptake was unaffected by vanadate or
valinomycin, but abolished by bafilomycin and nigericin (Table 2), suggesting that Cd
transport is due
to a proton antiporter dependent on the pH gradient generated by the
vacuolar ATPase. Vacuolar vesicles will quench acridine orange
fluorescence upon addition of ATP, although not if 0.5 µM bafilomycin is present, indicating that acidification of the
intravesicular space is mediated by the vacuolar proton ATPase.
Fluorescence is restored upon addition of 6 µM CdCl
to these vesicles, suggesting that Cd
influx is
accompanied by proton efflux (not shown).
Figure 6:
Vacuolar vesicle uptake of substrates
related to PC complexes. Vesicles derived from LK100/pDH35 (
,
) and LK100/pART (
,
) were tested as in Fig. 2A in the presence (
,
) or absence
(
,
) of 3 mM ATP for uptake of the following
substrates: A, 8 µM
CdCl
(100 mCi/mmol); B, 50 µM [
H]GSDNP. Arrow indicates addition
of Triton X-100 to 0.02%. Bars represent
S.E.
HMT1-dependent Uptake of Cd
Complexed
with PCs
Because apo-PCs and Cd
ions can enter
the vacuole through separate routes it is important to determine if PCs
and Cd
are taken up as a complex as well. Inhibition
of the V-ATPase with bafilomycin abolishes vacuolar vesicle uptake of
Cd but does not affect transport of
S-labeled PCs ( Table 2and Table 3). When
vacuolar vesicles derived from the HMT1 hyperproducing strain
LK100/pDH35 were incubated with a LMW [
Cd]
PC
Cd substrate in the presence of bafilomycin, ATP-dependent
uptake of the
Cd radiolabel was observed (Table 3).
Vacuolar vesicles derived from HMT1-deficient LK100/pART, on the other
hand, exhibit relatively little uptake of the LMW
[
Cd]PC
Cd complex in the presence of
bafilomycin. As previously shown, vanadate impairs HMT1 transport of
the LMW [
S]PC
Cd complex but does not
inhibit the Cd
/H
antiporter (Table 2). Uptake of LMW
[
Cd]PC
Cd by LK100/pDH35 vesicles was
reduced by 69% in the presence of vanadate (Table 3), similar to
the 61% inhibition observed for uptake of LMW
[
S]PC
Cd. These data are consistent with
HMT1-mediated uptake of PC
Cd complexes by vacuolar vesicles. To
determine if the Cd
/H
antiporter is
capable of recognizing Cd
bound to PCs, LK100/pART
vesicles were incubated with LMW [
Cd]PC
Cd
in the absence of bafilomycin. Uptake of the
Cd label
under these conditions (7.1 ± 0.3 nmol/min/mg) was only 19% of
that observed when Cd
is presented as the free metal
ion (37 ± 1 nmol/min/mg).
Cysteine, GSH, and Dinitrophenyl-GSH
PCs are
synthesized from GSH, and are in a sense GSH polymers. However,
vacuolar membrane vesicles do not take up [
H]GSH
in either the reduced (GSH) or oxidized (GSSG) forms (not shown). GSH
itself has affinity for heavy metals, and the Candida glabrata HMW PC
Cd
S
complex has been shown to
contain GSH(25) . However, [
H]GSH was not
taken up by vacuolar vesicles in the presence of Cd
.
This was also true when [
S]cysteine was tested
as a possible substrate.Recent reports indicate that plant vacuoles
contain a transporter that recognizes various GSH
conjugates(40) , including GSDNP which is recognized with high
affinity. HMT1 function might be a part of a more generalized
xenobiotic detoxification pathway involving sequestration of GSH
conjugates produced by glutathione S-transferases. Vacuolar
membrane vesicles exhibited ATP-dependent
[
H]GSDNP uptake (Fig. 6B) that
was abolished at 0 °C, or when ATP was substituted with AMP, ADP,
or AMP-PNP. Unlike PC transport, however, vacuolar vesicles derived
from LK100/pART1 or LK100/pDH35 exhibited no significant difference
regarding [
H]GSDNP uptake. Thus, fission yeast
vacuoles contain a GSH-conjugate transporter that is distinct from
HMT1. GSDNP transport was similar to HMT1-mediated PC uptake in that it
was not inhibited by proton ionophores or bafilomycin, but was
significantly reduced in the presence of 0.1 mM vanadate (not
shown).
DISCUSSION
It has been established that PCs are essential for heavy
metal tolerance in S. pombe(13) , and may also play an
important role in plants(12) . However, PC synthesis in and of
itself is not sufficient to confer heavy metal tolerance. Yeast strains
harboring a mutant hmt1 allele are Cd
sensitive, notwithstanding their ability to synthesize PCs. In
this work we have shown that the native HMT1 protein is sorted to the
vacuolar membrane of S. pombe. We also report the discovery of
a novel PC transport activity in S. pombe vacuolar membrane
vesicles. PC uptake correlates with HMT1 abundance and is inhibited by
antibodies directed against this protein, indicating that HMT1 is most
likely responsible for PC transport into the vacuole. PC uptake by
vacuolar vesicles appears to be directly energized by ATP hydrolysis,
as expected of an ABC-type transporter. It is not dependent on activity
of the vacuolar proton ATPase, or sensitive to ionophores that
dissipate the
pH or membrane potential. Similar to other ABC-type
proteins, such as the cystic fibrosis transmembrane regulator (41) and P-glycoprotein(42) , HMT1-mediated PC uptake
is supported by ribonucleotides other than ATP and is inhibited by
vanadate.
HMT1 is capable of transporting both apo-PCs (measured as
uptake of [
S]PC) and PC
Cd complexes
(measured as uptake of LMW [
Cd]PC
Cd). The
HMW PC
Cd
S
complex is also taken up by
vacuolar vesicles containing HMT1, albeit with lower efficiency. Some
ABC-type transporters exhibit wide substrate specificity. The multiple
drug resistance P-glycoprotein, for example, recognizes many
structurally-unrelated drugs, and the TAP1 and TAP2 transporters
mobilize peptides sharing very little, if any, amino acid sequence
similarity(43) . Thus, recognition of various types of PC
substrates by HMT1 would not be unprecedented. However, further study
is required to determine if the HMW PC
Cd
S
complex or apo-PCs represent bona fide substrates in vivo. The simplest model for the role of HMT1 in heavy metal tolerance
involves transport of PC-metal complexes into the vacuole as
illustrated in Fig. 7. The accumulation of PCs in the vacuoles
of Cd
-treated plant seedlings (45) might be
explained by the presence of an HMT1-like activity in the tonoplast.
Figure 7:
A model
of PC-mediated cadmium tolerance. Cd
ions taken up by
the cell activate PC synthase (44) and induce synthesis of PCs,
which chelate cytoplasmic Cd
to form the LMW
PC
Cd complex. HMT1 actively transports the LMW PC
Cd complex
across the vacuolar membrane and sulfide is added within the vacuole to
generate the stable HMW PC
Cd
S
complex.
In this model, LMW PC
Cd functions as a cytoplasmic carrier,
whereas the HMW PC
Cd
S
complex is the
storage form of the metal. Since the ratio of Cd
to
PC is higher in the HMW complex than in the LMW complex, additional
Cd
could be supplied by the
Cd
/H
antiporter. Apo-PCs may also be
transported by HMT1, while Cd
enters through the
Cd
/H
antiporter.
HMT1 may not be dedicated exclusively to heavy metal tolerance.
Micronutrients such as copper or zinc, complexed with PCs, might be
stored in the vacuole via HMT1 transport and released to the cytoplasm
as required. PC
Cu and PC
Zn complexes, which can activate
some apo-metalloenzymes as efficiently as free metals(46) ,
have been shown to be a less toxic source of cofactors than free metal
ions(47) .
S. pombe vacuolar vesicles also exhibit
ATP-dependent uptake of
Cd in the absence of PCs.
However, this activity is not attributable to HMT1 as it is present at
approximately the same level in a strain that hyperproduces this
protein and a mutant which does not contain detectable levels of the
HMT1 polypeptide. Cd
uptake appears to be mediated by
a Cd
/H
antiporter that depends on
the pH gradient generated by a vacuolar proton ATPase. A similar
activity residing in the tonoplast of oat roots has been
described(48) . The role of the Cd
transporter in heavy metal tolerance remains unclear.
Sequestration of free Cd
ions in the vacuole should
ameliorate their toxicity. However, LK100 cells, which contain an
active Cd
transporter, are still extremely sensitive
to Cd
. Plant cells exposed to Cd
contain very little, if any, of the free metal ion(47) .
Intracellular Cd
appears to be found almost
exclusively as PC
Cd complexes. This is in accordance with our
observations which indicate that S. pombe extracts contain
very little free Cd
(not shown). Furthermore, we find
that PC bound Cd
is not an efficient substrate for
the Cd
transporter. Thus, the major route for
sequestration of Cd
in the vacuole may be uptake of
PC
Cd complexes by HMT1. It is possible that the Cd
transporter is required when heavy metal first enters the cell
and PC levels are low, or when a metal challenge exhausts the
short-term capacity of the cell to synthesize stoichiometric amounts of
PCs. Alternatively, Cd
may represent an adventitious
substrate and the ``Cd
'' transporter may be
involved in some aspect of metal homeostasis unrelated to
Cd
tolerance. In S. cerevisiae and N.
crassa, a battery of antiporters maintain vacuolar pools of
Ca
, polyphosphate, and various amino acids, helping
to regulate the cytoplasmic levels of these substances (reviewed in (49) ). A metal antiporter may serve a similar function.
To
our knowledge, HMT1 represents the first reported ABC-type transporter
conferring tolerance to a toxic substance by sequestration in an
intracellular membrane-bound compartment. The pfmdr1 gene
product, implicated in chloroquine resistance, is localized to the
digestive vacuole of Plasmodium falciparum(50) ;
however, hyperproduction of this protein results in a 40-50-fold
decrease in intracellular levels of the drug. S. pombe vacuoles also contain a glutathione conjugate transporter, which
like HMT1 is insensitive to inhibitors of the vacuolar ATPase and
sensitive to vanadate, suggesting by analogy that an ABC-type protein
might be responsible. Recently, transport activities for glutathione
conjugates (40) and bile acids (51) were found in the
plant tonoplast. In both cases, it was hypothesized that ABC-type
proteins were involved. Organisms are exposed to a large number of
toxic compounds of both exogenous and endogenous origin. Conjugation of
the toxins or their derivatives with ubiquitous intracellular
metabolites such as glutathione, glucuronate, and sulfate is one way in
which cells deal with this problem. In animals, a number of these
conjugates are exported from the cell and then excreted from the
organism. It appears that in plants and fungi, toxins
``tagged'' by conjugation (or chelation in the case of heavy
metals) are sequestered in the vacuole, and that ABC-type transporters
may play a major role in these detoxification pathways.
FOOTNOTES
- *
- This work was supported by U. S. Department of
Agriculture Grant ARS 5335-23000-005-00D (to D. W. O.) and National
Research Initiative Competitive Grant P92-37100-7627 (to D. F. O.). The
costs of publication of this article were defrayed in part by the
payment of page charges. This article must therefore by hereby marked
``advertisement'' in accordance with 18 U.S.C.
Section 1734 solely to indicate this fact.
- §
- Present address: Dept. of Physiology, Tufts
Medical School, Boston, MA 02111.
- ¶
- To whom
correspondence should be addressed. Tel.: 510-559-5909; Fax:
510-559-5678.
- (
) - The abbreviations used are: ABC,
ATP-binding cassette; AMP-PNP, adenosine
5`-(
,
-imido)triphosphate; GSH, glutathione; GSDNP,
dinitrophenyl-S-glutathione; HMW, high molecular weight; LMW,
low molecular weight; PC, phytochelatin; hmt, heavy metal tolerance;
MES, 4-morpholineethanesulfonic acid; CHAPS,
3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonic
acid; HPLC, high performance liquid chromatography.
ACKNOWLEDGEMENTS
We thank H. A. Koshinsky and T. Zankel for critical
reading of the manuscript.
REFERENCES
- Higgins, C. F. (1992) Annu. Rev. Cell Biol. 8, 67-113
[CrossRef]
- Ortiz, D. F., Kreppel, L., Speiser, D. M., Scheel G., McDonald, G., and Ow, D. W. (1992) EMBO J. 11, 3491-3499
[Medline]
[Order article via Infotrieve]
- Kamijo, K., Taketani, S., Yokota, S., Osumi, T., and Hashimoto, T. (1990) J. Biol. Chem. 265, 4534-4540
[Abstract/Free Full Text]
- Gartner, J., Moser, H., and Valle, D. (1992) Nature Genet. 1, 16-23
[CrossRef][Medline]
[Order article via Infotrieve]
- Kleijmeer, M. J., Kelly, A., Geuze, H. J., Slot, J. W., Townsend, A., and Trowsdale, J. (1992) Nature 357, 342-344
[CrossRef][Medline]
[Order article via Infotrieve]
- Kane, S. E., Pastan, I., and Gottesman, M. M. (1990) J. Bioenerg. Biomembr. 22, 593-618
[CrossRef][Medline]
[Order article via Infotrieve]
- Nishi, K., Yoshida, M., Nishimura, M., Nishikawa, M., Nishiyama, Horinouchi, S., and Beppu, T. (1992) Mol. Microbiol. 6, 761-769
[Medline]
[Order article via Infotrieve]
- Balzi, E., Wang, M., Leterme, S., Van Dyck, L., and Goffeau, A. (1994) J. Biol. Chem. 269, 2206-2214
[Abstract/Free Full Text]
- Callahan, H. L., and Beverley, S. (1991) J. Biol. Chem. 266, 18427-18430
[Abstract/Free Full Text]
- Fath, M. J., and Kolter, R. (1993) Microbiol. Rev. 57, 995-1017
[Abstract/Free Full Text]
- Grill, E., Winnacker, E. L., and Zenk, M. H. (1985) Science 230, 674-676
[Abstract/Free Full Text]
- Steffens, J. C., Hunt, D. F., and Williams, B. G. (1986) J. Biol. Chem. 261, 13879-13882
[Abstract/Free Full Text]
- Ow, D. W., Ortiz, D. F., Speiser, D. M., and McCue, K. F. (1994) in Metal Ions in Fungi (Winkelmann, G., and Winge, D. R., eds) pp. 339-359, Marcel Dekker, New York
- Murasugi, A., Wada, C., and Hayashi, Y. (1983) J. Biochem. (Tokyo) 93, 661-664
[Abstract/Free Full Text]
- Reese, R. N., White, C. A., and Winge, D. R. (1992) Plant Physiol. 98, 225-229
[Abstract/Free Full Text]
- Speiser, D. M., Abrahamson, S. L., Banuelos, G., and Ow, D. W. (1992) Plant Physiol. 99, 817-821
[Abstract/Free Full Text]
- Speiser, D. M., Ortiz, D. F., Kreppel, L., Scheel G., McDonald, G., and Ow, D. W. (1992) Mol. Cell. Biol. 12, 5301-5310
[Abstract/Free Full Text]
- Juang, H. R., McCue, K. F., and Ow, D. W. (1993) Arch. Biochem. Biophys. 304, 392-401
[CrossRef][Medline]
[Order article via Infotrieve]
- Dameron, C. T., Reese, R. N., Mehra, R. K., Kortan, A. R., Carrol, P. J., Steigerwald, M. L., Brus, L. E., and Winge, D. R. (1989) Nature 338, 596-597
[CrossRef]
- Reese, R. N., and Winge, D. R. (1988) J. Biol. Chem. 263, 12832-12835
[Abstract/Free Full Text]
- Roberts, C. J., Raymond, C. K., Yamashiro, C. T., and Stevens, T. H. (1991) Methods Enzymol. 194, 644-661
[Medline]
[Order article via Infotrieve]
- Ackrell, B. A. C., Kearney, E. B., and Singer, T. P. (1978) Methods Enzymol. 53, 466-483
[Medline]
[Order article via Infotrieve]
- Seeger, M., and Payne, G. S. (1992) J. Cell Biol. 118, 531-540
[Abstract/Free Full Text]
- Crider, B. P., Xie, X. S., and Stone, D. K. (1994) J. Biol. Chem 269, 17379-17381
[Abstract/Free Full Text]
- Dameron, C. T., Smith, B. R., and Winge, D. R. (1989) J. Biol. Chem. 264, 17355-17360
[Abstract/Free Full Text]
- Grill, E., Winnacker, E. L., and Zenk, M. H. (1986) FEBS Lett. 197, 115-120
[CrossRef]
- Anderson, M. E. (1985) Methods Enzymol. 113, 548-555
[Medline]
[Order article via Infotrieve]
- Kondo, T., Dale, G. L., and Beutler, E. (1980) Proc. Natl. Acad. Sci. U. S. A. 77, 6359-6362
[Abstract/Free Full Text]
- Awasti, Y. C., Garg, H. S., Dao, D. D., Partridge, C. A., and Srivastava, S. K. (1981) Blood 58, 733-742
[Abstract/Free Full Text]
- Cooper, A., and Bussey, H. (1992) J. Cell Biol. 119, 1459-1468
[Abstract/Free Full Text]
- Roberts, C. J., Nophwehr, S. F., and Stevens, T. H. (1992) J. Cell Biol. 119, 69-83
[Abstract/Free Full Text]
- Kamimoto, Y., Gatmaitan, Z., Hsu, J., and Arias, I. M. (1989) J. Biol. Chem. 264, 11693-11698
[Abstract/Free Full Text]
- Zhang, J. T., and Ling, V. (1991) J. Biol. Chem. 266, 18224-18232
[Abstract/Free Full Text]
- Silve, S., Volland, C. G., Garnier, R. J., Chevallier, M. R., and Haguenauer-Tsapis, R. (1991) Mol. Cell. Biol. 11, 1114-1124
[Abstract/Free Full Text]
- Wilkinson, G. N. (1961) Biochem. J. 80, 324-332
[Medline]
[Order article via Infotrieve]
- Ohsumi, Y., and Anraku, Y. (1981) J. Biol. Chem. 256, 2079-2082
[Abstract/Free Full Text]
- Zerez, C. R., Weiss, R. L., Franklin, F., and Bowman, B. J. (1986) J. Biol. Chem. 261, 8877-8882
[Abstract/Free Full Text]
- Plocke, D. J., and Kagi, J. H. R. (1992) Eur. J. Biochem. 207, 201-205
[Medline]
[Order article via Infotrieve]
- Abrahamson, S. L., Speiser, D. M., and Ow, D. W. (1992) Anal. Biochem. 200, 239-243
[CrossRef][Medline]
[Order article via Infotrieve]
- Martinoia, E., Grill, E., Tommasinni, R., Kreuz, K., and Amrheim, N. (1993) Nature 364, 247-249
[CrossRef]
- Anderson, M. P., Berger, H. A., Rich, D. P., Gregory, R. J., Smith, A. E., and Welsh, M. J. (1991) Cell 67, 775-784
[CrossRef][Medline]
[Order article via Infotrieve]
- Lelong, H. H., Padmanabhan, R., Lovelace, E., Pastan, I., and Gottesman, M. M. (1992) FEBS Lett. 304, 256-260
[CrossRef][Medline]
[Order article via Infotrieve]
- Sheperd, J. C., Schumacher, T. N. M., Ashton-Rickardt, P. G., Imaeda, S., Ploegh, H. L., Janeway, C. A., Jr., and Tonegawa, S. (1993) Cell 74, 577-584
[CrossRef][Medline]
[Order article via Infotrieve]
- Grill, E., Loffler, S., Winnacker, E. L., and Zenk, M. H. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 6838-6842
[Abstract/Free Full Text]
- Vogeli-Lange, R., and Wagner, G. J. (1990) Plant Physiol. 92, 1086-1093
[Abstract/Free Full Text]
- Thumann, J., Grill, E., Winnacker, E. L., and Zenk, M. H. (1991) FEBS Lett. 284, 66-69
[CrossRef][Medline]
[Order article via Infotrieve]
- Kneer, R., and Zenk, M. H. (1992) Phytochemistry 31, 2663-2667
[CrossRef]
- Salt, D. E., and Wagner, G. J. (1993) J. Biol. Chem. 268, 12297-12302
[Abstract/Free Full Text]
- Cowman, A. F., Karz, S., Galatis, D., and Culvenor, J. G. (1991) J. Cell Biol. 113, 1033-1042
[Abstract/Free Full Text]
- Klionsky, D. J., Herman, P. K., and Emr, S. D. (1990) Microbiol. Rev. 54, 266-292
[Abstract/Free Full Text]
- Hortensteiner, S., Vogt, E., Hagenbuch, B., Meier, P. J., Amrheim, N., and Martinoia, E. (1993) J. Biol. Chem. 268, 18446-18449
[Abstract/Free Full Text]
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg